Rechallenge of Imatinib in GIST Having no Effective Treatment: RIGHT

NCT01151852 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: Imatinib
DRUG: Placebo

Sponsor

Asan Medical Center